Dr Reddys unveils generic version of Rozerem Tablets in US for treating insomnia
The product is a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration (USFDA).
New Delhi: Drugmaker, Dr Reddy’s Laboratories Ltd. has announced the launch of Ramelteon Tablets, 8 mg indicated for the treatment of insomnia in the US market.
The product is a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration (USFDA).
Dr Reddy’s Ramelteon Tablets are available as 8 mg tablets in bottle count sizes of 30, 100, and 1000.
"Rozerem is a trademark of Takeda Pharmaceutical Company Limited," the drug major said
"The Rozerem brand had U.S. sales of approximately $91.3 million MAT for the most recent twelve months ending in May 2019 according to IQVIA Health," the company added.
Also Read: Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd